HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ABBV-324 enters first human tests for tough cancers
Disease control Recruiting nowThis early-stage study tests an experimental drug called ABBV-324 in about 232 adults with liver cancer (hepatocellular cancer) or a type of lung cancer (squamous non-small cell lung cancer). The main goals are to check safety and see if the drug shrinks tumors. Participants rece…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 29, 2026 00:49 UTC
-
New pill plus immunotherapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental oral drug called 7HP349 (Alintegimod) combined with standard immunotherapy drugs (ipilimumab and nivolumab) in adults with advanced solid tumors like melanoma, lung, kidney, or liver cancer that have not responded to prior treatments. The goal is …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC